Supply resiliency during unprecedented times

The Coronavirus pandemic reveals how vulnerable the drug supply chain can be. In this episode, we will discuss what frontline pharmacists need to know to ensure essential medications are available and the drug supply remains resilient.
 
Guest speakers:
Doug Kucera
Associate Vice President
Contract Services, Pharmacy
Vizient
 
Mittal Sutaria, PharmD
Vice President
Contract and Program Services, Pharmacy
Vizient
 
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
 
Show Notes:
[01:31] Demand for Propofol for COVID ventilated patients skyrocketed to 272%
[01:52] Private label programs provides resiliency to the market
[02:41] How to strengthen pharmacy supply chain
[03:55] Drug shortage task force objectives
[06:00] Essential Medication Lists
[06:57] Labor cost for managing drug shortages
[08:10] Prioritize Essential Medication List and educate others   
[08:35] Elevate the transparency, accountability and resiliency of the pharmaceutical supply chain  
[10:08] Frontline pharmacist advocacy plays a huge role
[10:45] Ask questions to make sure the solution is in the best interest for your pharmacy
 
Links | Resources:
Vizient’s Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of propofol as COVID-19 Cases Surged, Click here
Essential Medications for Patient Care, Click here
Drug shortages and labor costs: Measuring a hidden cost of drug shortages on U.S. hospitals, Click here
Essential medications review (November 2020), Click here
Vizient Identifies Essential Medications in Hospitals and Highlights Fragility of the Supply Chain, Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Google Podcasts
Stitcher
Android
RSS Feed